Information received by medtronic indicated an inaccurate sensor reading that triggered a suspend.On november 16, 2021, it was reported that the blood glucose was 251 mg/dl and the sensor glucose was 62 mg/dl, which is outside of the acceptable range.The customer was previously hospitalized for 8 days starting on (b)(6) 2021 with a high bg of 400 mg/dl and symptoms including nausea, vomiting, and abdominal pain.The customer declined troubleshooting.No further patient complications were reported.After hospitalization, the customer changed their pump settings with the assistance of their hcp and continued to use the device.The device is not expected to return to medtronic.
|